Man Who Predicted Bitcoin Says "This is Bigger"

From Legacy Research | Ad

He called Tesla in 2018... and Bitcoin in 2015... now he says a brand-new financial technology could unleash a Quadrillion-dollar impact starting 2021.

Learn More Here!

TBPH Insider Trading (Theravance Biopharma)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $399,033.00

Theravance Biopharma Insider Trading History Chart

Theravance Biopharma Share Price & Price History

^$7.02

▼ -0.07 (-0.99%)

As of 09/24/2021 01:00 AM ET

Days: 30 | 90 | 365

Man Who Predicted Bitcoin In 2015: "This Is Bigger"

From Legacy Research | Ad

Why are Billionaires like Elon Musk, Mark Cuban & Michael Jordan Investing in This Odd New Technology?

Learn more.

Theravance Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2021	Philip D Worboys	SVP	Sell	8,829	$20.00	$176,580.00	343,679
12/14/2020	Richard A Graham	SVP	Sell	7,500	$19.47	$146,025.00	123,749
12/3/2020	Philip D Worboys	SVP	Sell	4,246	$18.00	$76,428.00	319,395
8/21/2020	Brett K Haumann	Insider	Sell	25,000	$18.29	$457,250.00	307,810
8/20/2020	Philip D Worboys	SVP	Sell	17,103	$18.00	$307,854.00	333,252
12/12/2019	Vijay Sabesan	SVP	Sell	1,027	$21.03	$21,597.81	145,253
5/17/2019	Donal O'connor	Director	Sell	4,000	$20.46	$81,840.00	30,244
3/5/2019	Sharathchandra S Hegde	SVP	Sell	9,033	$24.71	$223,205.43	270,134

Insider Selling at Theravance Biopharma?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Theravance Biopharma and related companies.

SEC Filings (Institutional Ownership Changes) for Theravance Biopharma (NASDAQ:TBPH)

82.11% of Theravance Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Theravance Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/7/2021	Newbridge Financial Services Group Inc.	2,000	$29K	0.0%	N/A	0.003%
8/17/2021	Walleye Capital LLC	16,688	$0.24M	0.0%	N/A	0.023%
8/17/2021	Woodline Partners LP	374,912	$5.44M	0.1%	N/A	0.510%
8/17/2021	Invesco Ltd.	21,812	$0.32M	0.0%	+77.3%	0.030%
8/17/2021	Millennium Management LLC	150,551	$2.19M	0.0%	+26.7%	0.205%
8/17/2021	Price T Rowe Associates Inc. MD	35,837	$0.52M	0.0%	-5.1%	0.049%
8/17/2021	Caas Capital Management LP	61,450	$0.89M	0.0%	N/A	0.084%
8/16/2021	Bank of America Corp DE	71,576	$1.04M	0.0%	-30.0%	0.097%
8/16/2021	UBS Asset Management Americas Inc.	63,921	$0.93M	0.0%	+5.1%	0.087%
8/16/2021	California State Teachers Retirement System	73,457	$1.07M	0.0%	+4.4%	0.100%
8/16/2021	Royal Bank of Canada	25,056	$0.36M	0.0%	+17.4%	0.034%
8/16/2021	Credit Suisse AG	62,722	$0.91M	0.0%	+28.4%	0.085%
8/16/2021	Maven Securities LTD	1,342,574	$20.13M	0.8%	N/A	1.827%
8/16/2021	Charles Schwab Investment Management Inc.	356,544	$5.18M	0.0%	+6.9%	0.485%
8/16/2021	State Street Corp	1,256,058	$18.24M	0.0%	+9.0%	1.710%
8/16/2021	Nuveen Asset Management LLC	187,672	$2.73M	0.0%	-2.2%	0.255%
8/16/2021	Goldman Sachs Group Inc.	287,759	$4.18M	0.0%	+2.4%	0.392%
8/16/2021	Macquarie Group Ltd.	290,258	$4.22M	0.0%	+256.3%	0.395%
8/13/2021	Northern Trust Corp	560,933	$8.14M	0.0%	+8.0%	0.763%
8/13/2021	Altium Capital Management LP	220,000	$3.19M	0.7%	N/A	0.299%
8/13/2021	Laurion Capital Management LP	1,094,936	$15.90M	0.1%	+55.4%	1.490%
8/13/2021	Tekla Capital Management LLC	656,296	$9.53M	0.3%	+43.8%	0.893%
8/13/2021	Geode Capital Management LLC	932,268	$13.54M	0.0%	+11.2%	1.269%
8/13/2021	Vanguard Group Inc.	5,278,969	$76.65M	0.0%	+16.9%	7.185%
8/13/2021	FMR LLC	10,791,863	$156.70M	0.0%	+10.9%	14.689%
8/13/2021	ProShare Advisors LLC	25,560	$0.37M	0.0%	+19.6%	0.035%
8/12/2021	XTX Topco Ltd	14,269	$0.21M	0.1%	N/A	0.019%
8/12/2021	SG Americas Securities LLC	8,042	$0.12M	0.0%	N/A	0.011%
8/12/2021	The Manufacturers Life Insurance Company	29,791	$0.43M	0.0%	+14.4%	0.041%
8/12/2021	Monashee Investment Management LLC	200,000	$2.90M	0.3%	N/A	0.272%
8/12/2021	Bridgefront Capital LLC	15,714	$0.23M	0.1%	N/A	0.021%
8/11/2021	BlackRock Inc.	4,520,707	$65.64M	0.0%	-2.4%	6.153%
8/11/2021	Deutsche Bank AG	37,238	$0.54M	0.0%	-81.8%	0.057%
8/11/2021	Panagora Asset Management Inc.	179,200	$2.60M	0.0%	-4.2%	0.275%
8/10/2021	Virtus ETF Advisers LLC	26,643	$0.39M	0.2%	-18.9%	0.041%
8/10/2021	Principal Financial Group Inc.	14,850	$0.22M	0.0%	+5.2%	0.023%
8/10/2021	BNP Paribas Arbitrage SA	2,073	$30K	0.0%	-70.5%	0.003%
8/10/2021	State Board of Administration of Florida Retirement System	26,461	$0.38M	0.0%	+9.3%	0.041%
8/10/2021	Citigroup Inc.	9,905	$0.14M	0.0%	+57.7%	0.015%
8/6/2021	Mutual of America Capital Management LLC	79,290	$1.15M	0.0%	-4.1%	0.121%
8/6/2021	Swiss National Bank	119,042	$1.73M	0.0%	+16.3%	0.182%
8/5/2021	Rhumbline Advisers	58,411	$0.85M	0.0%	-5.0%	0.089%
8/5/2021	DekaBank Deutsche Girozentrale	51,250	$0.76M	0.0%	-22.6%	0.079%
8/3/2021	Handelsbanken Fonder AB	13,516	$0.20M	0.0%	N/A	0.021%
8/3/2021	Peregrine Capital Management LLC	459,716	$6.68M	0.1%	-5.1%	0.704%
8/2/2021	Arizona State Retirement System	12,174	$0.18M	0.0%	-6.6%	0.019%
8/2/2021	New York State Common Retirement Fund	47,694	$0.69M	0.0%	+15.2%	0.073%
5/24/2021	Principal Financial Group Inc.	14,110	$0.29M	0.0%	-40.7%	0.022%
5/22/2021	Teachers Retirement System of The State of Kentucky	38,459	$0.79M	0.0%	-5.4%	0.059%
5/18/2021	Millennium Management LLC	118,869	$2.43M	0.0%	+390.1%	0.182%
5/18/2021	D. E. Shaw & Co. Inc.	56,014	$1.14M	0.0%	+59.8%	0.086%
5/18/2021	Jane Street Group LLC	14,192	$0.29M	0.0%	N/A	0.022%
5/17/2021	Virtus ETF Advisers LLC	32,871	$0.67M	0.3%	+2.8%	0.050%
5/17/2021	Royal Bank of Canada	21,345	$0.44M	0.0%	-3.6%	0.033%
5/17/2021	Price T Rowe Associates Inc. MD	37,774	$0.77M	0.0%	-91.5%	0.058%
5/17/2021	DAFNA Capital Management LLC	41,165	$0.84M	0.2%	N/A	0.063%
5/17/2021	Ameriprise Financial Inc.	15,431	$0.32M	0.0%	-95.5%	0.024%
5/17/2021	Hennion & Walsh Asset Management Inc.	102,548	$2.09M	0.1%	N/A	0.157%
5/17/2021	HRT Financial LP	9,830	$0.20M	0.0%	N/A	0.015%
5/17/2021	Nuveen Asset Management LLC	191,887	$3.92M	0.0%	+0.9%	0.294%
5/17/2021	Goldman Sachs Group Inc.	281,120	$5.74M	0.0%	-19.6%	0.431%
5/14/2021	Laurion Capital Management LP	704,608	$14.38M	0.1%	+9.9%	1.079%
5/14/2021	First Mercantile Trust Co.	4,907	$100K	0.0%	-15.8%	0.008%
5/14/2021	Credit Suisse AG	48,834	$1M	0.0%	-21.9%	0.075%
5/13/2021	Mutual of America Capital Management LLC	82,700	$1.69M	0.0%	-5.3%	0.127%
5/13/2021	Citigroup Inc.	6,279	$0.13M	0.0%	-69.9%	0.010%
5/13/2021	Bank of Montreal Can	1,603	$35K	0.0%	-78.9%	0.002%
5/12/2021	Northern Trust Corp	519,230	$10.60M	0.0%	-3.6%	0.795%
5/12/2021	Ergoteles LLC	14,500	$0.30M	0.0%	N/A	0.022%
5/12/2021	Geode Capital Management LLC	838,363	$17.11M	0.0%	+11.1%	1.284%
5/12/2021	CM Management LLC	50,000	$1.02M	0.8%	N/A	0.077%
5/12/2021	Panagora Asset Management Inc.	187,115	$3.82M	0.0%	+1.2%	0.287%
5/12/2021	Sei Investments Co.	32,260	$0.66M	0.0%	-2.1%	0.049%
5/12/2021	UBS Group AG	219,038	$4.47M	0.0%	+30.2%	0.336%
5/11/2021	Peregrine Capital Management LLC	484,206	$9.88M	0.2%	-12.3%	0.742%
5/10/2021	Russell Investments Group Ltd.	87,122	$1.78M	0.0%	-15.6%	0.134%
5/10/2021	State Board of Administration of Florida Retirement System	24,208	$0.49M	0.0%	-14.9%	0.037%
5/10/2021	Principal Financial Group Inc.	14,110	$0.29M	0.0%	-40.7%	0.022%
5/7/2021	BlackRock Inc.	4,634,135	$94.58M	0.0%	+3.2%	7.106%
5/7/2021	BNP Paribas Arbitrage SA	7,028	$0.14M	0.0%	-27.9%	0.011%
5/7/2021	Swiss National Bank	102,342	$2.09M	0.0%	+2.3%	0.157%
5/6/2021	Rhumbline Advisers	61,515	$1.26M	0.0%	-6.0%	0.094%
5/6/2021	Alliancebernstein L.P.	70,735	$1.44M	0.0%	-7.8%	0.108%
5/3/2021	The Manufacturers Life Insurance Company	26,036	$0.53M	0.0%	-5.6%	0.040%
4/26/2021	NJ State Employees Deferred Compensation Plan	58,142	$1.19M	0.2%	+52.4%	0.089%
3/26/2021	Susquehanna International Group LLP	11,081	$0.20M	0.0%	-50.3%	0.017%
3/12/2021	DekaBank Deutsche Girozentrale	66,250	$1.17M	0.0%	+91.8%	0.103%
3/4/2021	Hudson Bay Capital Management LP	275,000	$4.89M	0.0%	-14.1%	0.427%
3/2/2021	Norges Bank	657,681	$11.69M	0.0%	N/A	1.028%
3/1/2021	UBS Asset Management Americas Inc.	60,794	$1.08M	0.0%	+40.0%	0.095%
2/23/2021	Principal Financial Group Inc.	23,776	$0.42M	0.0%	+105.8%	0.037%
2/19/2021	JPMorgan Chase & Co.	36,515	$0.65M	0.0%	+113.0%	0.057%
2/16/2021	Tri Locum Partners LP	49,373	$0.88M	0.3%	N/A	0.077%
2/16/2021	Nuveen Asset Management LLC	190,160	$3.38M	0.0%	-9.3%	0.297%
2/16/2021	Price T Rowe Associates Inc. MD	446,451	$7.93M	0.0%	-18.0%	0.698%
2/16/2021	Engineers Gate Manager LP	18,051	$0.32M	0.0%	N/A	0.028%
2/16/2021	Charles Schwab Investment Management Inc.	323,578	$5.75M	0.0%	+3.2%	0.506%
2/12/2021	Laurion Capital Management LP	641,235	$11.40M	0.1%	+3,191.6%	1.002%
2/12/2021	Allstate Corp	12,407	$0.22M	0.0%	N/A	0.019%
2/12/2021	CWM Advisors LLC	11,718	$0.21M	0.0%	N/A	0.018%

Data available starting January 2016

Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused in the areas of inflammation and immunology. In pursuit of its purpose, Theravance Biopharma applies insights and innovation at each stage of its business and utilizes its internal capabilities and those of partners around the world. The Company applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. These efforts leverage years of experience in developing lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its pipeline of internally discovered programs is targeted to address significant patient needs. Theravance Biopharma has an economic interest in potential future payments from Glaxo Group Limited or one of its affiliates (GSK) pursuant to its agreements with Innoviva, Inc. relating to certain programs, including TRELEGY. For more information, please visit www.theravance.com.

Today's Range

Now: $7.02

$6.98

$7.20

50 Day Range

MA: $10.84

$6.77

$14.17

52 Week Range

Now: $7.02

$6.10

$22.74

Volume

451,728 shs

Average Volume

659,066 shs

Market Capitalization

$515.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of Theravance Biopharma?: Theravance Biopharma's top insider shareholders include:
Philip D Worboys (SVP)
Brett K Haumann (Insider)
Vijay Sabesan (SVP)
Richard A Graham (SVP)
Who are the major institutional investors of Theravance Biopharma?: Theravance Biopharma's top institutional shareholders include:
FMR LLC — 14.69%
Vanguard Group Inc. — 7.19%
BlackRock Inc. — 6.15%
Maven Securities LTD — 1.83%
State Street Corp — 1.71%
Laurion Capital Management LP — 1.49%
Which major investors are selling Theravance Biopharma stock?: During the last quarter, TBPH stock was sold by these institutional investors:
Deutsche Bank AG
BlackRock Inc.
Susquehanna International Group LLP
Bank of America Corp DE
Peregrine Capital Management LLC
DekaBank Deutsche Girozentrale
Panagora Asset Management Inc.
Virtus ETF Advisers LLC
Within the previous year, company insiders that have sold Theravance Biopharma company stock include:
Philip D Worboys (SVP)
Brett K Haumann (Insider)
Which major investors are buying Theravance Biopharma stock?: During the previous quarter, TBPH stock was bought by institutional investors including:
Maven Securities LTD
FMR LLC
Vanguard Group Inc.
Laurion Capital Management LP
Woodline Partners LP
Altium Capital Management LP
Macquarie Group Ltd.
Tekla Capital Management LLC

MarketBeat's Top 5 Stock Picks - Just Released

From MarketBeat | Ad

MarketBeat has just released five new trading ideas, but Tesla, Apple, and Netflix didn't make the cut. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Now, MarketBeat thinks these five stocks may be even better buys.

View the Stocks Here